Table 1.

HSCT outcomes in patients with acute myelogenous leukemia (haplo versus matched sibling donor-MSD, matched unrelated donor-MUD, and unrelated cord blood-UCB).

	HAPLO	MSD	MUD	UCB
Transplant-Related Mortality	18%	24%	33%	35%
CD4+ T cells/μL at day +100	190	229	106	63
Cumulative incidence of CMV antigenaemia	74%	58%	60%	68%
Infection incidence at day +100:
Bacterial	25%	23%	36%	39%
Fungal	11%	4%	14%	14%
Rate of fatal infections	11%	4%	14%	17%